Pancreatic Cancer Global Clinical Trial Landscape (2024)

Pancreatic cancer is one of the most fatal gastrointestinal cancers. However, since 2019, the biotech and biopharma industry has initiated over 2,000 pancreatic cancer trials with North America leading in the number of trials conducted, followed by Asia-Pacific and Europe. In this free paper, discover the latest insight and data on global pancreatic cancer clinical trials in 2024, including the funding and drug development landscapes, prospects, and the opportunities they present for trial providers.